ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,474,612 | +29.3% | 999,249 | +25.4% | 0.03% | +34.8% |
| Q2 2023 | $15,834,900 | +47.1% | 796,925 | +26.8% | 0.02% | +35.3% |
| Q1 2023 | $10,766,445 | +147.8% | 628,514 | +183.1% | 0.02% | +112.5% |
| Q4 2022 | $4,344,540 | -48.0% | 222,000 | +17.6% | 0.01% | -38.5% |
| Q2 2021 | $8,357,000 | -0.2% | 188,698 | 0.0% | 0.01% | -7.1% |
| Q1 2021 | $8,373,000 | -54.0% | 188,698 | -43.2% | 0.01% | -56.2% |
| Q4 2020 | $18,215,000 | +202.2% | 332,143 | +26.0% | 0.03% | +166.7% |
| Q3 2020 | $6,027,000 | -32.0% | 263,642 | -37.8% | 0.01% | -36.8% |
| Q2 2020 | $8,867,000 | +85.3% | 423,637 | +23.5% | 0.02% | +46.2% |
| Q1 2020 | $4,785,000 | +1.9% | 343,000 | +66.2% | 0.01% | +30.0% |
| Q4 2019 | $4,698,000 | – | 206,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |